Epizyme, Inc.
SMYD INHIBITORS
Last updated:
Abstract:
The present disclosure provides carboxamides and sulfonamides having Formula (I): and the pharmaceutically acceptable salts and solvates thereof, wherein A, Y, B, X, and Z are defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula (I) to treat a disorder responsive to the blockade of SMYD proteins such a SMYD3 or SMYD2. Compounds of the present disclosure are especially useful for treating cancer. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
1 May 2020
Issue date:
1 Jul 2021